Ginsenosides attenuate kainic acid-induced synaptosomal oxidative stress via stimulation of adenosine A2A receptors in rat hippocampus

Behavioural Brain Research

Volumn 197, Issue 1, 2009, Pages 239-245

  Shin, Eun Joo ^a   Koh, Young Ho ^b   Kim, A Young ^b   Nah, Seung Yeoul ^c   Jeong, Ji Hoon ^d   Chae, Jong Seok ^a   Kim, Sun Cheol ^a   Yen, Tran Phi Hoang ^e   Yoon, Hyoung Jong ^a   Kim, Won Ki ^f   Ko, Kwang Ho ^g   Kim, Hyoung Chun ^a  

^a Kangwon National University   (South Korea)

^b Hallym University   (South Korea)

^c Konkuk University   (South Korea)

^d Chung Ang University   (South Korea)

^e University of Medicine and Pharmacy of Ho Chi Minh City   (Viet Nam)

^f Korea University College of Medicine   (South Korea)

^g Seoul National University   (South Korea)

Author keywords

Adenosine A2A receptor; Ginsenosides; Hippocampus; Kainate; Oxidative stress; Synaptosome

Indexed keywords

8 (3 CHLOROSTYRYL)CAFFEINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE A2A RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ALLOXAZINE; GINSENOSIDE; KAINIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HIPPOCAMPUS; MALE; NERVE ENDING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

ANALYSIS OF VARIANCE; ANIMALS; CAFFEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; GINSENOSIDES; HIPPOCAMPUS; KAINIC ACID; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; SEIZURES; STATISTICS, NONPARAMETRIC; SYNAPTOSOMES;

EID: 57649210760     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.08.038     Document Type: Article

References (40)

1. Ando N., Morimoto K., Watanabe T., Ninomiya T., and Suwaki H. Enhancement of central dopaminergic activity in the kainate model of temporal lobe epilepsy: implication for the mechanism of epileptic psychosis. Neuropsychopharmacology 29 (2004) 1251-1258
2. Attele A.S., Wu J.A., and Yuan C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol. 58 (1999) 1685-1693
3. Carswell H.V., Graham D.I., and Stone T.W. Kainate-evoked release of adenosine from the hippocampus of the anaesthetised rat: possible involvement of free radicals. J. Neurochem. 68 (1997) 240-247
4. Csernansky J.G., Csernansky C.A., Kogelman L., Montgomery E.M., and Bardgett M.E. Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implication for schizophrenia. Biol. Psychiatry 44 (1998) 1143-1150
5. 3H]GABA release from rat hippocampus nerve terminals. Neuropharmacology 39 7 (2000) 1156-1167
6. Dazzi L., Serra M., Porceddu M.L., Sanna A., Chessa M.F., and Biggio G. Enhancement of basal and pentylenetetrazol (PTZ)-stimulated dopamine release in the brain of feely moving rats by PTZ-induced kindling. Synapse 26 (1997) 351-358
7. De Mendonca A., Sebastiao A.M., and Ribeiro J.A. Adenosine: does it have a neuroprotective role after all?. Brain Res. Rev. 33 (2000) 258-274
8. Dunwiddie T.V. The physiological role of adenosine in the central nervous system. Int. Rev. Neurobiol. 27 (1985) 63-139
9. 1 adenosine receptors in rat hippocampus after kainic acid-induced limbic seizures. Neurosci. Lett. 284 (2000) 49-52
10. Ferr S., Fredholm B.B., Morelli M., and Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20 (1997) 482-487
11. Fredholm B.B., Chen J.F., Cunha R.A., Svenningsson P., and Vaugeois J.M. Adenosine and brain function. Int. Rev. Neurobiol. 63 (2005) 191-270
12. Gale K. Role of GABA in the genesis of chemconvulsant seizures. Toxicol. Lett. 64-65 (1992) 417-428
13. 1 adenosine receptors in human temporal lobe epilepsy. Brain Res. 710 (1996) 56-68
14. 13C NMR spectroscopy. J. Neurochem. 74 (2000) 327-333
15. 3H]-AMPA binding sites in rat hippocampus. Br. J. Pharmacol. 115 (1995) 295-301
16. 2A adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells. J. Biol. Chem. 276 17 (2001) 13838-13846
17. 2A receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci. Lett. 329 (2002) 289-292
18. Hunter R.L., Dragicevic N., Seifert K., Choi D.Y., Liu M., Kim H.C., et al. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigristriatal system. J. Neurochem. 100 (2007) 1375-1386
19. 2A receptor agonists and antagonists. Neuroscience 85 (1998) 229-237
20. Kim H.C., Jhoo W.K., Bing G., Shin E.J., Wie M.B., Kim W.K., et al. Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms. Brain Res. 874 (2000) 15-23
21. 1 receptor modulation in the rat. Neurosci. Lett. 355 (2004) 231-235
22. Kwon Y.S., Ann H.S., Nabeshima T., Shin E.J., Kim W.K., Jhoo J.H., et al. Selegiline potentiates the effects of EGb 761 in response to ischemic brain injury. Neurochem. Int. 45 (2004) 157-170
23. Lebel C.P., and Bondy S.C. Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem. Int. 17 (1990) 435-440
24. Lee F.S., and Chao M.V. Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc. Natl. Acad. Sci. U.S.A. 98 6 (2001) 3555-3560
25. Lee J.H., Kim S.R., Bae C.S., Kim D., Hong H., and Nah S. Protective effect of ginsenosides, active ingredients of Panax ginseng, on kainic acid-induced neurotoxicity in rat hippocampus. Neurosci. Lett. 325 (2002) 129-133
26. 2A receptors activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann. Neurol. 49 6 (2001) 727-735
27. Namba T., Yoshizaki T., Tominori K., Kobayashi K., Mitsui K., and Hasse J. Fundamental studies on the evaluation of the crude drugs (I). Planta Med. 32 (1974) 588-594
28. Nicholls D.G. The glutamatergic nerve terminal. Eur. J. Biochem. 212 (1993) 613-631
29. Popoli P., Minghetti L., Tebano M.T., Pintor A., Domenici M.R., and Massotti M. Adenosine A2A receptor antagonism and neuroprotection: mechanisms, lights, and shadows. Crit. Rev. Neurobiol. 16 1-2 (2004) 99-106
30. Racine R.J. Modification of seizure activity by electric stimulation: II. Motor seizure. EEG Clin. Neurophysiol. 32 (1972) 281-294
31. 2A receptors in the hippocampus and striatum of the rat. Neuroscience 132 (2005) 893-903
32. Robledo P., Ursu G., and Mahy N. Effects of adenosine and gamma-aminobutyric acid A receptor antagonists on N-methyl-d-aspartate induced neurotoxicity in the rat hippocampus. Hippocampus 9 5 (1999) 527-533
33. 2A receptors: possible involvements of the striatal reduction in AP-1 DNA binding activity and proenkephalin gene expression. Behav. Brain Res. 158 (2005) 143-157
34. Shin E.J., Jeong J.H., Bing G., Park E.S., Chae J.S., Yen T.P.H., et al. Kainate-induced mitochondrial oxidative stress contributes to hippocampal degeneration in senescence-accelerated mice. Cell Signal 20 (2008) 645-658
35. Shin E.J., Ko K.H., Kim W.K., Chae J.S., Yen T.P., Kim H.J., et al. Role of glutathione peroxidase in the ontogeny of hippocampal oxidative stress and kainate seizure sensitivity in the genetically epilepsy-prone rats. Neurochem. Int. 52 (2008) 1134-1147
36. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42 (1997) 1-32
37. Strecker R.E., and Moneta M.E. Electrical stimulation of the kindled hippocampus briefly increases excellular dopamine in the nucleus accumbens. Neurosci. Lett. 176 (1994) 173-177
38. 2A receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus. J. Neurochem. 104 1 (2008) 279-286
39. Whittaker V.P., Michaelson I.A., and Kirkland R.J. The separation of synaptic vesicles from nerve-ending particles ("synaptosomes"). Biochem. J. 90 (1964) 293-303
40. Yuan C.S., Wu J.A., Lowell T., and Gu M. Gut and brain effects of American ginseng root on brainstem neuronal activities in rats. Am. J. Chin. Med. 26 (1998) 47-55